Lihe Kechuang: Lihe Yunji has not carried out experimental verification against monkeypox virus yet
Lihe Kechuang said on the interactive platform that Lihe Yunji has not carried out experimental verification against monkeypox virus yet. Liheyunji's self disinfection and sterilization anti-virus functional material has the advantages of efficacy durability, safety and broad-spectrum effectiveness, and has not been applied to the field of mask production.
This text is a result of machine translation.
Related companies：
Briefing Jun 10, 2022 02:09 PM
· Technology
Ningde times: the industrialization layout of sodium ion battery has been started, and a basic industrial chain will be formed in 2023
Briefing Jun 01, 2022 10:34 AM
· Consumer Staples
China Merchants Securities: maintain the "recommended" rating on Alibaba and look forward to the development prospect of global business
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Briefing May 24, 2022 02:24 PM
· Healthcare
Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Nov 16, 2022 05:19 PM
Nov 08, 2022 08:32 AM
Briefing May 21, 2022 06:44 AM
· Financials
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
Automotive · Analysis
2025: New Approaches to Global Traffic Acquisition
From impulsive decision-making to systematic analysis, traffic acquisition in cross-border e-commerce, content creation, and global gaming is no longer just a numbers game—it has become a battle of precision and efficiency. As traditional traffic operation strategies lose effectiveness, companies expanding overseas face a key challenge: how to achieve the highest conversions with the lowest cost.
Feb 21, 2025 04:05 PM
Healthcare
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
In-depth
Healthcare, Financials, Automotive · Analysis
Manufacturing Glass for the Automobile Industry: Fuyao Group
You may remember Fuyao from the 2019 Netflix documentary, 'American Factory.' While the documentary lays out the story of the Chinese company’s foray into America based on social issues, here you will find out about the business side.
May 27, 2020 07:45 PM
Briefing Apr 18, 2022 10:18 PM
· Technology
A number of enterprises on the science and innovation board are listed on the "white list" of key enterprises for operation guarantee and transfer
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
The First Move of the U.S. Postal Service on Cross-Border E-commerce After Trump
Feb 21, 2025 08:19 PM
Insight
In-depth
Insight
In-depth
Insight
In-depth
Automotive · Analysis
Shanghai and Shenzhen: The Dual-City Landscape and Corporate Power
Jan 09, 2025 03:35 PM